BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1507415)

  • 21. Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.
    Geller RB; Myers S; Devine S; Larson RA; Williams SF; Park CL; O'Toole K; Chandler C; Topper RL
    Bone Marrow Transplant; 1992 Jan; 9(1):41-7. PubMed ID: 1543948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ablative therapy in bone marrow transplantation.
    Rybka WB
    Bone Marrow Transplant; 1991; 7 Suppl 1():60. PubMed ID: 1675139
    [No Abstract]   [Full Text] [Related]  

  • 23. Current status of allogeneic bone marrow transplantation in leukemia: a report from the International Bone Marrow Transplant Registry.
    Bortin MM; Gale RP
    Clin Transpl; 1987; ():127-40. PubMed ID: 3154378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation.
    Vogler WR; Winton EF; Heffner LT; Gordon DS; Sternberg P; Crocker I; Reynolds R; Dobbs CK
    Bone Marrow Transplant; 1990 Dec; 6(6):405-9. PubMed ID: 2097009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Minimal residual disease in leukemia and lymphoma: biological significance and clinical applications].
    Gavosto F; Saglìo G; Foà R
    Haematologica; 1989 Oct; 74(5 Suppl):85-95. PubMed ID: 2512235
    [No Abstract]   [Full Text] [Related]  

  • 26. New conditioning regimens for high risk marrow transplants.
    Jones RJ; Santos GW
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():15-7. PubMed ID: 2627618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developments in purging in autotransplantation.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):687-715. PubMed ID: 8344886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour cell purging for autologous bone marrow transplantation.
    Trickett AE
    Med Lab Sci; 1990 Apr; 47(2):120-31. PubMed ID: 2199741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autologous bone marrow transplantation in pediatric cancer].
    Ohira M
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2299-306. PubMed ID: 2260867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EBMT experience of autologous bone marrow transplantation in lymphoma.
    Goldstone AH; Gribben JG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):505-8. PubMed ID: 2480299
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.
    Geller RB
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma.
    Brandwein JM; Callum J; Sutcliffe SB; Scott JG; Keating A
    Bone Marrow Transplant; 1990 Nov; 6(5):291-4. PubMed ID: 2291991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological bone marrow purging with drugs other than cyclophosphamide derivatives.
    Douay L
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():195. PubMed ID: 2469509
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary function changes 100 days and one year after bone marrow transplantation.
    Badier M; Guillot C; Delpierre S; Vanuxem P; Blaise D; Maraninchi D
    Bone Marrow Transplant; 1993 Nov; 12(5):457-61. PubMed ID: 8298556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is body weight a risk factor of interstitial pneumonitis after bone marrow transplantation?
    Ozsahin M; Schwartz LH; Pene F; Touboul E; Schlienger M; Laugier A
    Bone Marrow Transplant; 1992 Jul; 10(1):97. PubMed ID: 1515887
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: critical review of syngeneic, autologous, and allogeneic transplants.
    Champlin RE; Gale RP
    Cancer Treat Rep; 1984 Jan; 68(1):145-61. PubMed ID: 6362862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current status of autologous bone marrow transplantation in Japan].
    Harada M
    Rinsho Ketsueki; 1985 Jun; 26(6):886-7. PubMed ID: 3906173
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience in psychosocial management of cancer patients undergoing bone marrow transplantation].
    Weis J; Köchlin G
    Psychother Psychosom Med Psychol; 1993 May; 43(5):159-65. PubMed ID: 8327628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Initial experiences with pentamidine aerosol in prevention of Pneumocystis carinii pneumonia following bone marrow transplantation].
    Link H; Schwardt A; Vöhringer HF; Wingen FJ; Haen M; Ehninger G
    Med Klin (Munich); 1990 Apr; 85 Suppl 2():288-90. PubMed ID: 2374531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays.
    Atkinson K; Downs K; Ashby M; Biggs J
    Transplant Proc; 1990 Jun; 22(3):1331-4. PubMed ID: 2190395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.